CAS 1190239-42-9
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 2 productos.
Fasinumab
CAS:Fasinumab (anti-NGF mAb) is in Phase III trials for acute sciatica & knee OA. It significantly improves pain & function vs. placebo.Pureza:95%Forma y color:Liquid
